In vitro corticosteroid: correlation response with primary open-angle glaucoma and ocular corticosteroid sensitivity.

Area of Science:

• Immunology
• Ophthalmology
• Pharmacology

Background:

• Corticosteroids are known to inhibit human peripheral blood lymphocyte transformation.
• Primary open-angle glaucoma (POAG) is a leading cause of irreversible blindness.
• Individual responses to corticosteroid treatment, particularly in glaucoma, can vary significantly.

Purpose of the Study:

• To investigate the systemic sensitivity of circulating lymphocytes to corticosteroid compounds.
• To determine the correlation between in vitro lymphocyte corticosteroid sensitivity and in vivo ocular pressure response in patients with POAG.
• To explore the potential of in vitro cellular systems for understanding corticosteroid-induced ocular hypertension and POAG pathogenesis.

Main Methods:

• An in vitro study involving 100 patients with primary open-angle glaucoma.
• Assessment of varying degrees of ocular pressure responsiveness to corticosteroid testing.
• Systemic evaluation of corticosteroid sensitivity within circulating lymphocytes.

Main Results:

• Significant variations in corticosteroid sensitivity were observed in the circulating lymphocytes of patients.
• A high correlation was established between the level of corticosteroid sensitivity measured in lymphocytes and that observed in the eye.
• These findings suggest a systemic basis for individual differences in ocular response to corticosteroids.

Conclusions:

• In vitro lymphocyte corticosteroid sensitivity serves as a reliable indicator of ocular response.
• Cellular systems offer a valuable tool for elucidating the molecular mechanisms underlying variable corticosteroid responses.
• Understanding these mechanisms is crucial for advancing the study of corticosteroid-induced ocular hypertension and POAG.